CEOs do not control share price (certainly to the chagrin of those CEOs). I'm sure you know this. Many CUV investors were also in AVX. Things haven't worked out as well for our AVX friends.
Pharmaceutical microcaps typically either take off or crash. Some lose 90% (AVX). Some double (SPL). Some flatline in preparation for.... who knows what? (CUV)
I'm confident this company has designs on appreciation much greater than SPL. And since you still hold, I'm guessing you have the same trust. As do I.
wow!, page-2
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.46 |
Change
0.020(0.13%) |
Mkt cap ! $773.2M | |||
| Open | High | Low | Value | Volume |
| $15.62 | $15.63 | $15.36 | $200.0K | 12.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 221 | $15.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.50 | 159 | 9 |
View Market Depth
| Last trade - 13.05pm 17/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |